mBio is a premier, peer-reviewed open-access journal published by the American Society for Microbiology, dedicated to advancing the field of microbiology and virology. With an impressive impact factor and a commendable standing within the top quartiles (Q1) of both microbiology and virology categories as of 2023, mBio offers a dynamic platform for researchers and professionals to disseminate high-quality, rigorous scientific findings. Since its inception in 2010, it has served as a vital resource for the global scientific community, facilitating open access to groundbreaking research that spans diverse topics within microbiology. With a Scopus ranking of #28 out of 182 in Microbiology and #16 out of 80 in Virology, mBio significantly influences ongoing research trends and informs best practices in the field. Its commitment to open-access publishing allows for widespread visibility and accessibility, ensuring that critical discoveries reach a broad audience, including students and academics eager to contribute to, and learn from, cutting-edge science.

MICROBIOLOGY AND IMMUNOLOGY, an esteemed journal published by WILEY, serves as a vital resource for researchers and professionals in the fields of microbiology, immunology, and virology. With its ISSN 0385-5600 and E-ISSN 1348-0421, this journal has been a cornerstone in scientific literature since its inception in 1977, bridging decades of research and innovation through its comprehensive coverage of emerging trends and discoveries. Although this journal operates without open access, it maintains a commendable presence in academic circles, reflected in its 2023 Quartile rankings of Q3 across the categories of Immunology, Microbiology, and Virology. As part of an important discourse in these disciplines, MICROBIOLOGY AND IMMUNOLOGY ensures its scholarly contributions are relevant to both seasoned researchers and emerging scholars. Positioned in a competitive journal landscape, with Scopus ranks indicating a median percentile across its fields, it remains committed to advancing knowledge through peer-reviewed articles, thereby supporting the continuous evolution of its focus areas. The journal's current scope encompasses topics critical for understanding pathogen-host interactions and the immune response, making it a crucial publication for any academic library or individual scholar dedicated to the biological sciences.

The Canadian Journal of Microbiology, published by Canadian Science Publishing, is a well-respected journal established in 1954 that serves as a vital platform for advancing knowledge in the fields of microbiology and related disciplines. With an ISSN of 0008-4166 and an E-ISSN of 1480-3275, this journal is recognized for its rigorous peer-review process and its commitment to disseminating high-quality research that spans applied microbiology, biotechnology, genetics, immunology, and more. Currently indexed in several prestigious databases, its impact factor and category quartiles highlight its significance, ranking in the top tiers of applied microbiology and biotechnology as well as other intersecting fields. The journal provides an essential resource for researchers, professionals, and students seeking to stay informed on the latest advancements and breakthroughs, facilitating collaboration and innovation in the microbiological sciences. Set in the dynamic landscape of academia from its headquarters in Ottawa, Canada, the Canadian Journal of Microbiology remains steadfast in its mission to promote research that addresses key challenges and opportunities within the microbiological community.

CRITICAL REVIEWS IN MICROBIOLOGY, published by Taylor & Francis Ltd, is a leading peer-reviewed journal that has made significant contributions to the field of microbiology since its inception in 1971. With a prestigious Q1 ranking in Applied Microbiology and Biotechnology, as well as in Medicine and Microbiology, this journal is recognized for its high-quality reviews that synthesize current research and emerging trends in the discipline. Researchers and professionals rely on its comprehensive evaluations and critical insights, helping to advance knowledge and application in various microbiological contexts. Although the journal does not currently operate under an open access model, it remains an invaluable resource for academics seeking to stay at the forefront of microbiological advances. With a consistent publication record, CRITICAL REVIEWS IN MICROBIOLOGY continues to support the scholarly community by addressing key issues and innovations within the field.

MICROBIAL PATHOGENESIS, published by Academic Press Ltd - Elsevier Science Ltd, is a prominent journal in the fields of Infectious Diseases and Microbiology, with a notable impact factor and classified in the Q2 quartile for both categories as of 2023. Since its inception in 1986, this journal has provided a platform for the dissemination of cutting-edge research that enhances our understanding of microbial infections and their implications in health and disease. The journal is indexed in Scopus, ranking #80 among 344 in Infectious Diseases and #57 among 182 in Microbiology, underscoring its significant contribution to the scientific community. Although it operates under a traditional subscription model, the content is vital for researchers, professionals, and students focused on the dynamics of microbial pathogenesis and the development of innovative therapeutic strategies. The journal's comprehensive scope aims to foster advancements in this critical area of study, bridging the gap between laboratory research and clinical applications.

ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA is a distinguished academic journal published by AKADEMIAI KIADO ZRT, focusing on significant advancements in the fields of microbiology, immunology, and infectious diseases. Established in 1994, this journal serves as a vital platform for researchers, professionals, and students keen on exploring the complexities of microbial interactions and immune responses. With a current Impact Factor reflecting its rank within the Q3 categories for Immunology, Microbiology, and Infectious Diseases, it retains a critical position in disseminating innovative research. Although not open access, the journal provides extensive insights disseminated through various academic databases, ensuring a broad reach within the scholarly community. Its convergence over three decades indicates a robust commitment to excellence in scientific inquiry and knowledge sharing. As it moves towards the future, ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA continues to uphold its legacy of fostering collaborative research initiatives that contribute to the understanding and treatment of microbial diseases globally.

GERMS is a multidisciplinary journal published by the EUROPEAN ACAD HIV-AIDS & INFECTIOUS DISEASES, dedicated to advancing knowledge in the fields of epidemiology, immunology, infectious diseases, and microbiology. Since its inception in 2011, the journal has provided a crucial platform for researchers and practitioners to share innovative studies, clinical findings, and public health insights, with an eye on improving health outcomes globally. With an ISSN of 2248-2997 and a consistent publication trajectory leading up to 2024, GERMS is recognized in the third quartile across several categories, reflecting its growing impact and relevance in the scientific community. Authors and readers benefit from a range of access options, fostering the dissemination of vital research findings. As a journal situated in Romania, it also addresses regional health challenges while contributing to the broader discourse on infectious diseases and public health. GERMS is not just a repository of knowledge, but a vital resource for those engaged in combating infectious diseases and promoting health equity.

Microbiology Research, published by MDPI, stands as a pivotal open-access journal in the field of microbiology, having established its presence since 2010. Based in Switzerland, this journal strives to provide a platform for innovative research and cutting-edge findings in various branches of microbiology, including medical microbiology and molecular biology. With an impact factor that reflects its dedication to scholarly excellence, Microbiology Research is classified in the Q3 category for both microbiology and medical microbiology, and Q4 for molecular biology as of 2023, indicating its growing importance and outreach within these domains. The journal aims to foster discussion and collaboration among researchers, professionals, and students by presenting articles that cover a wide array of topics and methodologies in microbiological research. Leveraging its open-access model, Microbiology Research ensures that high-quality research is accessible to a global audience, thus facilitating the advancement of knowledge and innovation in the microbial sciences.

Welcome to the European Journal of Microbiology and Immunology, a premier platform dedicated to advancing the field of microbiology and immunology through the dissemination of high-quality research. Published by AKADEMIAI KIADO ZRT in Hungary, this journal serves as an essential resource for researchers, professionals, and students alike, fostering scholarly communication and innovation in these critical areas of medical science. The journal, which holds an ISSN of 2062-8633, presents rigorously peer-reviewed articles that contribute to our understanding of microbial diseases, immune responses, and related fields, currently ranking in the Q2 and Q3 quartiles across multiple categories such as immunology and microbiology. By embracing an inclusive scholarly dialogue and offering a robust readership, the European Journal of Microbiology and Immunology aims to inspire the next wave of discoveries and collaborations within the global scientific community.

Nature Microbiology is a premier journal published by NATURE PORTFOLIO that has firmly established itself within the realms of microbiological research since its inception in 2016. Based in the United Kingdom, this prestigious journal specializes in the intricacies of applied microbiology, cell biology, genetics, immunology, and medical microbiology, making it a cornerstone for academics and professionals alike. With an impressive Scopus ranking placing it in the top tier across various relevant categories—such as rank #3 in Genetics and #2 in Applied Microbiology—it underscores the journal’s commitment to high-quality, impactful research. Although it operates under a subscription model, Nature Microbiology's broad Open Access policy facilitates greater dissemination and visibility for its authors. The journal's objectives are centered around publishing cutting-edge advancements that enhance our understanding of microbial life, its interactions, and applications in health and disease. As a Q1 journal across multiple disciplines, it holds immense significance for researchers, professionals, and students enthusiastic about the latest innovations and breakthroughs in microbiology.